UK markets close in 5 hours 13 minutes

Protagonist Therapeutics, Inc. (PTGX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
34.02-0.01 (-0.03%)
At close: 04:00PM EDT
34.50 +0.48 (+1.41%)
After hours: 05:35PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
35,198
60,000
26,581
27,357
28,628
-
Operating expenses
Research development
134,704
120,161
126,215
126,006
74,506
-
Selling general and administrative
32,367
33,491
31,739
27,196
18,638
-
Total operating expenses
167,071
153,652
157,954
153,202
93,144
-
Operating income or loss
-131,873
-93,652
-131,373
-125,845
-64,516
-
Interest expense
-
-
0
0
598
169
Total other income/expenses net
-164
-201
-80
-149
-631
-
Income before tax
-130,106
-78,955
-127,393
-125,551
-64,845
-
Income tax expense
-
-
0
0
1,305
-691
Income from continuing operations
-130,106
-78,955
-127,393
-125,551
-66,150
-
Net income
-130,106
-78,955
-127,393
-125,551
-66,150
-
Net income available to common shareholders
-130,106
-78,955
-127,393
-125,551
-66,150
-
Basic EPS
-2.71
-1.39
-2.60
-2.71
-1.92
-
Diluted EPS
-2.71
-1.39
-2.60
-2.71
-1.92
-
Basic average shares
46,323
56,764
49,042
46,323
34,396
-
Diluted average shares
46,323
56,764
49,042
46,323
34,396
-